GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin’s lymphoma.

Ertan-Ahmed S., Kiehl M. G., Radinoff A., Graklanov V., Tzvetkov N., Mihăescu R., ...More

2019 ASCO Annual Meeting I, 31 May 2019

  • Publication Type: Conference Paper / Summary Text
  • Bilecik Şeyh Edebali University Affiliated: Yes